SOLV vs TECH
Solventum Corp. (SOLV) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Solventum Corp. (SOLV) is a medical instruments & supplies company listed on NYSE.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported SOLV revenue for 2024-12-31 was $8.25B. Net income was $479.0M. Revenue was up 0.7% from 2023-12-31 to 2024-12-31. SOLV currently screens at market cap $12.91B and trailing P/E 9.1.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
SOLV currently screens at market cap $12.91B and trailing P/E 9.1. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the SOLV and TECH stock pages for the full models.
Not investment advice.